ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Liebman who wrote (57)	3/10/1997 9:31:00 AM
From: Larry Liebman	of 4474

Ariad continues to look extremely attractive...Even, with the jump on recent news, it sits only a dollar or so higher than when Oppenheimer recommended it a month or so ago..HMR appears to be "using"/allying itself with ARIA to build a business in functional genomics...ARIA is apparently going to lose little cash while retaining a 50/50 stake in a new company...In addition HMR already is a partner in osteoporosis...I would also look to ARIA to sign up partners in both their Zap/autoimmune-inflammation program and their Syk/allergy-asthma program...This, without considering what might be the most interesting, the "gene-switch", which they are collaborating on with Genovo- a company I would like to hear more about...I particularly like the fact that Ariad is not "giving away the farm", and maintaining a significant equity position in its recent moves...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next